These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 388014)

  • 1. Migration inhibition factor activity in sera of patients with chronic lymphatic leukemia.
    Benjamin D; Aderka D; Livni E; Joshua H; Shaklai M; Pinkhas J
    J Natl Cancer Inst; 1979 Nov; 63(5):1175-7. PubMed ID: 388014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous release of leukocyte migration inhibition factor (LMIF) by lymphocytes in chronic lymphatic leukemia patients.
    Crivii SM; Crişan M; Crişan M
    Arch Geschwulstforsch; 1984; 54(1):85-9. PubMed ID: 6367694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease.
    Zou YQ; Lu LJ; Li SJ; Zeng T; Wang XD; Bao CD; Chen SL; Yang CD
    Clin Biochem; 2008 May; 41(7-8):519-24. PubMed ID: 18261992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis.
    Kitaichi N; Kotake S; Sasamoto Y; Namba K; Matsuda A; Ogasawara K; Onoé K; Matsuda H; Nishihira J
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):247-50. PubMed ID: 9888451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new parameter for chronic lymphocytic leukemia : determination of the large lymphocytes by means of Hemalog D (author's transl)].
    Vaugier G; Dighiero G; Charron D; Natali JC; Leporrier M; Debré P; d'Athis P; Binet JL
    Nouv Rev Fr Hematol (1978); 1978 Jun; 20(2):311-5. PubMed ID: 704345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage migration inhibitory factor (MIF).
    Aloisi AM; Pari G; Ceccarelli I; Vecchi I; Ietta F; Lodi L; Paulesu L
    Pain; 2005 May; 115(1-2):142-51. PubMed ID: 15836977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
    Sprong T; Pickkers P; Geurts-Moespot A; van der Ven-Jongekrijg J; Neeleman C; Knaup M; Leroy D; Calandra T; van der Meer JW; Sweep F; van Deuren M
    Shock; 2007 May; 27(5):482-7. PubMed ID: 17438452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [T-lymphocyte subpopulations in the blood of patients with chronic B-cell lympholeukemia studied using monoclonal antibodies].
    Karminskaia NM; Merson AG; Gipsh NM; Udris OIu; Iavorkovskiĭ LI
    Eksp Onkol; 1986; 8(3):50-3. PubMed ID: 2941268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
    Radstake TR; Sweep FC; Welsing P; Franke B; Vermeulen SH; Geurts-Moespot A; Calandra T; Donn R; van Riel PL
    Arthritis Rheum; 2005 Oct; 52(10):3020-9. PubMed ID: 16200611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
    van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA
    Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome.
    Willeke P; Gaubitz M; Schotte H; Maaser C; Domschke W; Schlüter B; Becker H
    Arthritis Res Ther; 2007; 9(2):R43. PubMed ID: 17470266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of macrophage migration inhibitory factor in the peripheral blood of women with endometriosis.
    Morin M; Bellehumeur C; Therriault MJ; Metz C; Maheux R; Akoum A
    Fertil Steril; 2005 Apr; 83(4):865-72. PubMed ID: 15820792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and disease progression.
    Muramaki M; Miyake H; Yamada Y; Hara I
    Oncol Rep; 2006 Jan; 15(1):253-7. PubMed ID: 16328065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel method to measure macrophage migration inhibitory factor (MIF) in sera of patients with rheumatoid arthritis by combined electrochemical immunosensor.
    Li S; Zhang R; Li P; Yi W; Zhang Z; Chen S; Su S; Zhao L; Hu C
    Int Immunopharmacol; 2008 Jun; 8(6):859-65. PubMed ID: 18442790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity, macrophage migration inhibitory factor, and weight loss.
    Church TS; Willis MS; Priest EL; Lamonte MJ; Earnest CP; Wilkinson WJ; Wilson DA; Giroir BP
    Int J Obes (Lond); 2005 Jun; 29(6):675-81. PubMed ID: 15795748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum levels of macrophage migration inhibitory factor in patients with Kawasaki disease.
    Lee TJ; Chun JK; Yeon SI; Shin JS; Kim DS
    Scand J Rheumatol; 2007; 36(3):222-5. PubMed ID: 17657678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage migration inhibitory factor in systemic lupus erythematosus.
    Foote A; Briganti EM; Kipen Y; Santos L; Leech M; Morand EF
    J Rheumatol; 2004 Feb; 31(2):268-73. PubMed ID: 14760795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum macrophage migration inhibitory factor (MIF) levels after allogeneic hematopoietic stem cell transplantation.
    Toubai T; Shono Y; Nishihira J; Ibata M; Suigita J; Kato N; Ohkawara T; Tone S; Lowler KP; Ota S; Tanaka J; Asaka M; Reddy P; Imamura M
    Int J Lab Hematol; 2009 Apr; 31(2):161-8. PubMed ID: 18081874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between macrophage migration inhibitory factor and cardiac function in patients with congestive heart failure].
    Liu Y; Yu XY; Lin QX; Yang M; Shan ZX; Zheng M
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1169-70. PubMed ID: 14625178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic validity of macrophage migration inhibitory factor in serum of patients with prostate cancer: a re-evaluation.
    Michael A; Stephan C; Kristiansen G; Burckhardt M; Loening SA; Schnorr D; Jung K
    Prostate; 2005 Jan; 62(1):34-9. PubMed ID: 15389818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.